SOUTH SAN FRANCISCO, Calif., Nov. 28 /PRNewswire-FirstCall/ --
Exelixis, Inc. (Nasdaq: EXEL) announced today that it will hold its Third
Annual R&D Day on Wednesday, December 5, 2007 from 10:00 a.m. ET / 7:00
a.m. PT to 2:00 p.m. ET / 11:00 a.m. PT in New York. The company will
discuss updates to its development pipeline, its collaborations, including
those with GSK, BMS and Genentech, and its financial outlook for 2007.
-- George Scangos, PhD, President & Chief Executive Officer of Exelixis,
-- Michael Morrissey, PhD, President of Research & Development of
-- Frank Karbe, Executive Vice President & Chief Financial Officer of
-- Peter Lamb, PhD, Senior Vice President, Discovery Research & Chief
Scientific Officer of Exelixis, Inc.
-- Gisela Schwab, MD, Senior Vice President and Chief Medical Officer of
-- Steven Sherman, MD of MD Anderson Cancer Center
-- Vince Miller, MD of Memorial Sloan-Kettering Cancer Center
The event will be webcast and may be accessed in the Event Calendar page under Investors at http://www.exelixis.com.
An archive of this webcast will be available until 9:00 p.m. PT/12:00 a.m. ET on January 4, 2008. Access numbers for this replay are: 1-888-286-8010 (domestic) and 1-617-801-6888 (international); the replay passcode number is: 21270665.
Exelixis, Inc. is a development-stage biotechnology company dedicated
to the discovery and development of novel small molecule therapeutics for
the treatment of cancer and other serious diseases. The company is
|SOURCE Exelixis, Inc.|
Copyright©2007 PR Newswire.
All rights reserved